Target intelligence / Profile preview

Nucleic acids and ribosomes

Molecular classification
Nucleic acid, Ribonucleoprotein complex, Macromolecular machine
01

Overview

Nucleic acids and ribosomes constitute the essential apparatus for the storage, transmission, and expression of genetic information. Nucleic acids, comprising deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), serve as the templates for life, while ribosomes are complex ribonucleoprotein machines responsible for translating genetic codes into functional proteins (Wilson, D. N., Nature Reviews Microbiology, 2014 [1]). In clinical practice, these entities are major therapeutic targets, particularly for antibiotics that exploit structural differences between prokaryotic and eukaryotic ribosomes to selectively inhibit bacterial protein synthesis (StatPearls, "Physiology, Ribosome", 2023 [2]). Additionally, many antineoplastic agents target DNA through intercalation, alkylation, or by inhibiting topoisomerases, thereby inducing DNA damage and apoptosis in rapidly dividing cancer cells (Pommier, Y., Nature Reviews Cancer, 2006 [3]). While highly effective, drugs targeting these systems often face challenges such as the development of molecular resistance and off-target toxicity, particularly when therapeutic agents cross-react with human mitochondrial machinery (Neidle, S., Nature Reviews Drug Discovery, 2002 [4]).

Other names
Genetic material and protein synthesis machineryDNA, RNA, and Ribosomal subunitsTranslational machinery
02

Mechanism of action

Inhibition of the 30S or 50S ribosomal subunits to prevent protein synthesis; inhibition of DNA topoisomerases or RNA polymerases to disrupt replication and transcription; direct DNA intercalation or alkylation to induce structural damage.

03

Biological functions

Genetic information storageTranscriptionTranslationProtein synthesisDNA replication
04

Disease associations

InfectionCancerGenetic disorders
05

Safety considerations

OtotoxicityNephrotoxicityBone marrow suppressionAntimicrobial resistanceMitochondrial toxicitySecondary malignancies
06

Interacting drugs

Gentamicin

7 more in the full profile.

07

Biomarkers

Bacterial 16S rRNADNA mutation statusRNA expression profilesMicrosatellite instability (MSI)gamma-H2AX

Beyond the preview

Go deeper on Nucleic acids and ribosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleic acids and ribosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call